https://www.viralvaxlab.com/vvl-publications-1/mucosal-vaccination-against-sars-cov-2-using-recombinant-influenza-viruses-delivering-self-assembling-nanoparticles 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/modulation-of-germinal-center-and-antibody-dynamics-via-ipsilateral-versus-contralateral-immunization-against-sars-cov-2 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/deconvoluting-tcr-dependent-and--independent-activation-is-vital-for-reliable-ag-specific-cd4%2B-t-cell-characterization-by-aim-assay 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/bivalent-mrna-booster-vaccination-recalls-cellular-and-antibody-immunity-against-antigenically-divergent-sars-cov-2-spike-antigens 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/low-level-human-memory-t-and-b-cells-recognising-avian-influenza-hemagglutinins-are-poorly-responsive-to-existing-seasonal-influenza-vaccines 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/deconvolution-of-cargo-delivery-and-immunogenicity-following-intranasal-delivery-of-mrna-lipid-nanoparticle-vaccines 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/impact-of-serum-versus-anticoagulant-containing-plasma-on-influenza-virus-neuraminidase-based-serological-assays 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/a-novel-chimeric-coronavirus-spike-vaccine-combining-sars-cov-2-rbd-and-scaffold-domains-from-hku-1-elicits-potent-neutralising-antibody-responses 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/randomized-controlled-trial-reveals-no-benefit-to-a-3-month-delay-in-covid-19-mrna-booster-vaccine 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/durable-reprogramming-of-neutralizing-antibody-responses-following-omicron-breakthrough-infection 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/cytokines-enhance-human-v%CE%B39v%CE%B42-t-cell-tcr-dependent-and-tcr-independent-effector-functions 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/sars-cov-2-breakthrough-infection-induces-rapid-memory-and-de-novo-t-cell-responses 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/engineered-ferritin-nanoparticle-vaccines-enable-rapid-screening-of-antibody-functionalization-to-boost-immune-responses 2025-12-18 https://www.viralvaxlab.com/vvl-publications-1/phenotypic-and-functional-characterization-of-pharmacologically-expanded-v%CE%B39v%CE%B42-t-cells-in-pigtail-macaques 2025-12-18